In part 1 of this series, Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, explains how patient outcomes impact primary and secondary prevention and related treatment costs.
Less than 40% of individuals with familial hypercholesterolemia (FH) receive appropriate high-intensity statin therapy, according to new research.
Low and high concentrations of high-density lipoprotein cholesterol (HDL-C) may be associated with an increased risk of infectious disease in the general population, according to new findings.
High variability in weight, blood pressure (BP), cholesterol, and blood sugar levels in otherwise healthy individuals could predict mortality and cardiovascular events, according to the results of a recent study.
Guideline-recommended thresholds for statin initiation may be too low, according to the results of a recent study.